Aug 20
Should Everyone be on GLP-1s?
GLP-1 receptor agonists are one of the most revolutionary new classes of drugs in decades. In this episode of Healthy Dialogue, host Derek C. Angus, MD, MPH, sat down with Jens Juul Holst, MD, DMSc, and Lotte Bjerre Knudsen, DMSc, 2 pioneering scientists behind the discovery and ... Show More
51m 54s
Aug 5
Food Politics, Obesity, and the "Wicked Mess" We're In
The United States has witnessed a staggering rise in obesity beginning in the early 1980s, leading to a wide array of important health consequences including heart disease, diabetes, and premature death. In this episode of Healthy Dialogue, Host Derek C. Angus, MD, MPH, talks wit ... Show More
47m 29s
Jul 22
Why and How Should the Government Fund Biomedical Research?
This episode of Healthy Dialogue explores the history and future of science funding in the US in light of recent changes, and proposed changes, from the federal government. Host Derek Angus, MD, MPH, speaks with former editor in chief of Science and a former director of the Natio ... Show More
47m 23s
Jul 2018
Aspirin, Stroke, Best Interests, Lasting Power of Attorney, Bawa Garba
If you are taking low dose aspirin - typically 75 mg day - to protect against heart attack or stroke and you haven't been weighed then there is a good chance you are on the wrong dose. And from prevention to treatment; a new way of managing the most common form of stroke by grabb ... Show More
27m 52s
Apr 2022
Apr 29, 2022 This Week in Cardiology Podcast
<p>Aspirin for primary prevention, time-restricted feeding, renal denervation, and a potential new obesity drug are the topics John Mandrola, MD, covers in this week's podcast.</p> <p><em>This podcast is intended for healthcare professionals only.</em> <u>To read a partial transc ... Show More
21m 33s
